Nicotine PK, PD & subjective effects of THS compared to cigarettes

  • Research type

    Research Study

  • Full title

    A single-center, randomized, controlled, open-label, cross-over study in currently smoking adult participants to investigate the nicotine pharmacokinetics and pharmacodynamics of Tobacco Heating System (THS) with LEVIA, a tobacco-free nicotine-containing product compared to THS with TEREA, a heated tobacco product and to cigarettes

  • IRAS ID

    355951

  • Contact name

    Amin Sammour

  • Contact email

    amin.sammour@celerion.com

  • Sponsor organisation

    Philip Morris Products S.A

  • Duration of Study in the UK

    0 years, 1 months, 4 days

  • Research summary

    This study will investigate how different nicotine products affect the body by comparing a tobacco-free nicotine product called LEVIA, a tobacco-containing product called TEREA, and regular cigarettes. Adult smokers will participate, using each product in different orders. The study will be conducted in two parts: one where participants use the products as they normally would over two periods and with two sequences, and another part where each product is tested on separate days using a more structured design called Williams design, with three periods and six sequences. The main goal is to compare how nicotine from each product is processed in the body and its effects on the participants.

    The duration of the entire study for each participant will be up to 37 days. This will include a screening period of up to 28 days (Day -30 to Day -2) prior to Admission (Day -1), 5 days of confinement (after enrollment) on Day -1 to time of Discharge on Day 5 (5 overnight stays), and a 3-day safety follow-up period (from time of Discharge on Day 5 or Early Termination plus three days).

  • REC name

    Wales REC 1

  • REC reference

    25/WA/0106

  • Date of REC Opinion

    9 May 2025

  • REC opinion

    Unfavourable Opinion